{"meshTags":["Adenocarcinoma","Aged","Antineoplastic Combined Chemotherapy Protocols","Chemotherapy, Adjuvant","Humans","Male","Neoadjuvant Therapy","Neoplasm Invasiveness","Pancreatic Neoplasms","Pancreaticoduodenectomy","Radiotherapy, Adjuvant","Tomography, X-Ray Computed","Treatment Outcome"],"meshMinor":["Adenocarcinoma","Aged","Antineoplastic Combined Chemotherapy Protocols","Chemotherapy, Adjuvant","Humans","Male","Neoadjuvant Therapy","Neoplasm Invasiveness","Pancreatic Neoplasms","Pancreaticoduodenectomy","Radiotherapy, Adjuvant","Tomography, X-Ray Computed","Treatment Outcome"],"publicationTypes":["Case Reports","Journal Article"],"abstract":"Pancreatic cancer is an aggressive malignancy, relatively resistant to chemotherapy and radiotherapy, which usually presents late. Disease specific mortality approaches unity despite advances in adjuvant therapy. We present the first reported case of complete pathological response following neoadjuvant therapy in a locally advanced pancreatic adenocarcinoma.","title":"Complete pathological response following down-staging chemoradiation in locally advanced pancreatic cancer: challenging the boundaries.","pubmedId":"18081235"}